Protecting Products versus Platforms

Nature Biotechnology, Vol. 34, pp. 462-65

NYLS Legal Studies Research Paper No. 2789281

4 Pages Posted: 5 Jun 2016

See all articles by Jacob S. Sherkow

Jacob S. Sherkow

University of Illinois College of Law; Carle Illinois College of Medicine; University of Illinois at Urbana-Champaign - European Union Center; University of Illinois at Urbana-Champaign - Carl R. Woese Institute for Genomic Biology

Date Written: May 1, 2016

Abstract

Patents have long been the most important legal assets of biotech companies. Increasingly, however, biotech firms find themselves on one side of a divide: as either traditional product companies or platform companies. Given the differences between these two types of business models, the merits of intellectual property (IP) protection vary between them. This article explores how those differences relate to biotech startups and entrepreneurs seeking to protect their inventions.

Keywords: patents, trade secrets, intellectual property, biotechnology, startups

JEL Classification: K00, K23, K41, O3, O34, D23, K11

Suggested Citation

Sherkow, Jacob S., Protecting Products versus Platforms (May 1, 2016). Nature Biotechnology, Vol. 34, pp. 462-65, NYLS Legal Studies Research Paper No. 2789281, Available at SSRN: https://ssrn.com/abstract=2789281

Jacob S. Sherkow (Contact Author)

University of Illinois College of Law ( email )

504 E. Pennsylvania Avenue
Champaign, IL 61820
United States

Carle Illinois College of Medicine ( email )

506 S Mathews Ave
Urbana, IL 61801
United States

University of Illinois at Urbana-Champaign - European Union Center ( email )

Coble Hall
801 S Wright St
Champaign, IL 61820

University of Illinois at Urbana-Champaign - Carl R. Woese Institute for Genomic Biology ( email )

Urbana, IL
United States

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
114
Abstract Views
735
Rank
436,129
PlumX Metrics